Source link : https://www.newshealth.biz/health-news/another-stab-at-disease-modifying-oa-drug-hits-home-in-early-study/
Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in pain and disability, said researchers with the drug’s developer. In a phase I study that also included placebo-controlled efficacy testing, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores for both knee pain and function were significantly lowered after […]
Author : News Health
Publish date : 2024-10-22 15:25:37
Copyright for syndicated content belongs to the linked Source.
